Viral Vector Delivery

Viral vectors remain foundational to many cell and gene therapy programs, but development and GMP scale-up require tight control of upstream production, downstream purification, and analytical characterization.

Artis BioSolutions supports viral vector programs through integrated development and GMP manufacturing aligned to clinical-stage requirements.

Platformized Viral Vector Execution

Our Platform Optimized for Scale-up and Transfer (POSTmark) AAV and lentiviral platforms use standardized, GMP- representative development workflows and mirrored systems to accelerate transfer into CGMP manufacturing. Integrated PD, AD, and QC teams reduce variability and shorten development-to-GMP timelines.